Scenture inks exclusive deal to distribute Rezennopy naloxone
Scenture Holdings (SCNX) entered an exclusive sales, marketing and distribution agreement to offer REZENOPY naloxone 10 mg via a partner network of about 2,000 U.S. OTP and addiction treatment centers.